Documents
Federal rules and notices from the public comment record, analyzed continuously.
FDA ▾
FDA Rare Disease Innovation Hub Future Programming; Request for Comments
17 comments · 1 awaiting analysis
Net support +100% across analyzed comments
Top issues in comments
- Rare disease regulatory flexibility
- Digital twins and in silico trials
- Equity in rare disease care
Citizen Petition from Tirza Eden
13 comments
Net support -8% across analyzed comments
Top issues in comments
- Wild horse protection
- Chemical spay safety and welfare
- Transparency and population counts
Butylated Hydroxytoluene (BHT); Request for Information
12 comments
Net support +75% across analyzed comments
Top issues in comments
- Cumulative dietary exposure
- Impact on animal food
- Supply chain impacts
Guidance for Industry; Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production
10 comments
Net support +40% across analyzed comments
Top issues in comments
- Retesting procedures
- Api storage conditions
- Contract laboratory responsibilities
Food Program Guidances Under Development - June 2021
9 comments
Net support 0% across analyzed comments
Top issues in comments
- Plant-based milk labeling
- Cross-contamination labeling
- Food allergy labeling on medications
Citizen Petition from Washington Action for Safe Water
8 comments · 1 awaiting analysis
Net support +100% across analyzed comments
Top issues in comments
- Fluoride as a drug
Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research Guidance for Industry - Final Guidance
7 comments
Net support 0% across analyzed comments
Top issues in comments
- Medical cannabis use
- Cannabis product regulation
- Dshea botanical classification
Citizen Petition from SafeVetMeds, Inc.
6 comments
Net support +100% across analyzed comments
Top issues in comments
- Adverse drug reactions
Implanted Brain-Computer Interface (BCI) Devices for Patients with Paralysis or Amputation - Non-clinical Testing and Clinical Considerations; Guidance for Industry and Food and Drug Administration Staff - Final Guidance
6 comments
Net support 0% across analyzed comments
Top issues in comments
- Unconsented bci removal
- Informed consent for neural data
The Declaration of Allulose and Calories from Allulose on Nutrition and Supplement Facts Labels: Guidance for Industry
5 comments
Net support +40% across analyzed comments
Top issues in comments
- Allulose labeling requirements
- Labeling requirements
- Bcaa caloric labeling
Citizen Petition from Covington & Burling LLP on Behalf of Novo Nordisk Inc.
5 comments · 2 awaiting analysis
Net support -33% across analyzed comments
Top issues in comments
- Compounded glp-1 access
- Compounding pharmacy access
Development of 21st Century Cures Act Section 3060 Required Report: Request for Input
4 comments · 1 awaiting analysis
Net support +100% across analyzed comments
Top issues in comments